Pharma News

Join WhatsApp Channel 

Crack GPAT — Prepare for GPAT Online 

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • The US Food and Drug Administration (FDA) has approved the VenaSeal closure system, first device to permanently treat varicose veins of leg by sealing them with an adhesive agent. The VenaSeal Closure system is manufactured by Covidien LLC, based in Morrisville, North Carolina.

  • According to business intelligence provider GBI (GlobalBusinessIntelligence) Research In 2013,  The US treatment market for rheumatoid arthritis (RA) was $6.4 billion and which get rising to $9.3 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 5.5%. Resaon behind this sudden growth  is US’ increasing prevalent population, which is reported  to hit 1.68 million by 2020. Consequently, marketcurrently makes up the  largest treatmentarea of the eight major pharmaceutical markets (the US, UK, Canada, France, Germany, Spain, Italy and Japan).

    [adsense:336x280:8701650588]

  • Australian researchers have developed a new genome editing technology that can target and kill blood cancer cells with high accuracy. Using the technology, researchers from the Walter and Eliza Hall Institute were able to kill human lymphoma cells by locating and deleting an essential gene for cancer cell survival.

  • The U.S. Food and Drug Administration granted approval to  Savaysa (edoxaban tablets) as anticlotting drug. This drug is used to reduce dangerous blood clots in patients with atrial fibrillation, deep vein thrombosis  and pulmonary embolism.

  • 4 April 2015
    MIT Scientists stand by Swine flu study

    Indian-origin scientists at MIT, who carried out a study which suggested that swine flu virus in India might have acquired genetic mutations to ay stood by their research and called the findings "accurate", even though the Indian government has disputed their claim.

  • 4 April 2015
    'National Biotechnology Development Strategy' Being drafted

    A policy to encourage life sciences education, research, and entrepreneurship, is being drafted, the government today informed the Lok Sabha. The draft policy, known as National Biotechnology Development Strategy 2, is currently under discussion with all senior experts and stakeholders for finalisation before its release.

  • Glioblastomas (GBM) are tumors that arise from astrocytes—the star-shaped cells that make up the “glue-like,” or supportive tissue of the brain. These tumors are usually highly malignant (cancerous) because the cells reproduce quickly and they are supported by a large network of blood vessels  Approximately 10,000 patients diagnosed each year in the US and approximately 1,600 patients diagnosed each year in Japan.

  • In India Dental treatments are 65 to 90 per cent cheaper than the developed world. The favourable cost-benefit ratio, quality and technological infrastructure in treatment attracting international patients from US, Europe, Middle East and South East Asian region to India.

Subscribe to Pharma News